Insomnia Treatment Market Trends, Size & Forecast by 2034

Insomnia Treatment Market Size and Forecasts (2021 - 2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Therapy Type (Non-pharmacological and Pharmacological Therapy); Drug Class (Melatonin Antagonist, Antidepressants, Benzodiazepines, No benzodiazepines); Route of Administration (Oral, Parenteral); Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy); and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00040845
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
Buy Now  
Insomnia Treatment Market Trends, Size & Forecast by 2034
Report Date: Jul 2026   |   Report Code: TIPRE00040845 Email: sales@theinsightpartners.com
Buy Now

Insomnia Treatment market size is expected to reach US$ 11.62 Billion by 2034 from US$ 7.10 Billion in 2025. The market is anticipated to register a CAGR of 5.63% during the forecast period 2026–2034.

The report presents an analysis based on therapy type (non-pharmacological and pharmacological therapy). The market is analyzed on the basis of drug class (melatonin antagonist, antidepressants, benzodiazepines, no benzodiazepines and others). The report further provides analysis based on route of administration (oral, parenteral and others). The report further provides analysis based on distribution channel (hospital pharmacy, online pharmacy and retail pharmacy). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.

Purpose of the Report

The report Insomnia Treatment Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Insomnia Treatment Market Segmentation

Therapy Type

  • Non-pharmacological and Pharmacological Therapy

Drug Class

  • Melatonin Antagonist
  • Antidepressants
  • Benzodiazepines
  • No benzodiazepines

Route of Administration

  • Oral
  • Parenteral

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy and Retail Pharmacy

Market Research Highlights

  • Global market for Insomnia Treatment was valued at US$ 7.10 Billion in 2025
  • Annual market size is expected to reach US$ 11.62 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 84.87 Billion
  • Market is anticipated to register a CAGR of 5.63% during the forecast period
  • The United States represents a key market, supported by Rising Prevalence of Sleep Disorders, Growing Awareness and Education, Aging Population, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Digital Therapeutics, Partnerships with Tech Companies, Expansion into Emerging Markets are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Pfizer Inc.,, Zydus Cadila,, MINERVA NEUROSCIENCES INC,, VIATRIS INC, Merck kgaa, EISAI, CO. LTD, Vanda Pharmaceuticals Inc., Sanofi, Takeda Pharmaceutical Company Ltd, CURRAX PHARMACEUTICALS LLC, while analyzing competitive strategies and innovation developments

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Insomnia Treatment Market: Strategic Insights

insomnia-treatment-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Insomnia Treatment Market Growth Drivers

  • Rising Prevalence of Sleep Disorders: The increasing incidence of insomnia and other sleep disorders, fueled by stress, anxiety, and lifestyle changes, is driving demand for effective treatments. As awareness grows, more individuals are seeking professional help, thus expanding the market for prescription and over-the-counter insomnia treatments.
  • Growing Awareness and Education: Increased awareness about the importance of sleep health is prompting individuals to seek solutions for insomnia. Educational campaigns highlighting the consequences of sleep deprivation are leading to higher consultation rates and the adoption of various treatment modalities, contributing to market growth.
  • Aging Population: The global aging population is a significant driver of the insomnia treatment market. Older adults are more likely to experience sleep disturbances due to various health issues. This demographic shift encourages the development of tailored treatments that cater to the unique needs of older adults, boosting market demand.

Insomnia Treatment Market Future Trends

  • Personalized Medicine: The trend toward personalized medicine is transforming insomnia treatment. By utilizing genetic insights and individual health data, manufacturers are developing tailored therapies that address specific sleep issues, resulting in more effective and targeted treatment outcomes for patients.
  • Integration of Mental Health Support: Recognizing the link between mental health and sleep quality, many insomnia treatments are incorporating psychological support. This trend involves combining cognitive behavioral therapy with pharmacological approaches, offering comprehensive solutions that address the root causes of insomnia while promoting better sleep hygiene.
  • Natural and Herbal Remedies: There is a growing trend towards the use of natural and herbal remedies for treating insomnia. Consumers are increasingly seeking organic and plant-based solutions, leading manufacturers to innovate and offer products that align with this preference for holistic and non-pharmaceutical options.

Insomnia Treatment Market Opportunities

  • Digital Therapeutics: The rise of digital therapeutics, including mobile applications and online therapy platforms, is reshaping insomnia treatment. These user-friendly tools provide cognitive behavioral therapy and sleep education, making effective treatment more accessible and appealing to a tech-savvy population seeking convenience in their healthcare solutions.
  • Partnerships with Tech Companies: Collaborating with technology companies to integrate insomnia treatments with health monitoring devices presents a unique opportunity. By creating combo solutions that track sleep patterns and offer tailored interventions, manufacturers can enhance product efficacy and attract a broader customer base.
  • Expansion into Emerging Markets: With rising awareness of sleep health, emerging markets present a significant growth opportunity. Manufacturers can capitalize on this by developing affordable insomnia treatments and educational initiatives, addressing the growing demand for effective sleep solutions in regions with increasing disposable incomes.

Insomnia Treatment Market Report Scope

Report Attribute Details
Market size in 2025 US$ 7.10 Billion
Market Size by 2034 US$ 11.62 Billion
Global CAGR (2026 - 2034) 5.63%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Therapy Type
  • Non-pharmacological and Pharmacological Therapy
By Drug Class
  • Melatonin Antagonist
  • Antidepressants
  • Benzodiazepines
  • No benzodiazepines
By Route of Administration
  • Oral
  • Parenteral
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy and Retail Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc.,
  • Zydus Cadila,
  • MINERVA NEUROSCIENCES INC,
  • VIATRIS INC
  • Merck kgaa
  • EISAI, CO. LTD
  • Vanda Pharmaceuticals Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Ltd
  • CURRAX PHARMACEUTICALS LLC

Insomnia Treatment Market Players Density: Understanding Its Impact on Business Dynamics

The Insomnia Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

insomnia-treatment-market-cagr

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Insomnia Treatment Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Insomnia Treatment Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The insomnia treatment market is estimated to witness a CAGR of 5.63% from 2026 to 2034

The major factors driving the insomnia treatment market are:
1. Rising Prevalence of Sleep Disorder
2. Growing Awareness and Education
3. Aging Population

North America region dominated the insomnia treatment market in 2025

Asia Pacific region dominated the insomnia treatment market in 2025

The non-pharmacological segment accounts for highest revenue in Therapy type sgement in 2025

Fresenius Kabi, Atom Pharma, PAI Pharma, Bayer Healthcare, Pfizer Inc., Johnson & Johnson, S.S.Pharmachem, Remedy Labs, Amar Healthcare, Wan Bury Limited are some fo the major market players operating in the market.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Apr 2026